Participants’ responsibilities in clinical research

Discussions on the ethics and regulation of clinical research have a great deal to say about the responsibilities of investigators, sponsors, research institutions and institutional review boards, but very little about the responsibilities of research participants. In this article, we discuss the responsibilities of participants in clinical research. We argue that competent adult participants are responsible for complying with study requirements and fulfilling other obligations they undertake when they make an informed choice to enrol in a study. These responsibilities are based on duties related to promise-keeping, avoiding harm to one's self or others, beneficence and reciprocity. Investigators and research staff should inform participants about their responsibilities during the consent process, and should stress the importance of fulfilling study requirements. They should address any impediments to compliance, and they may provide participants with financial incentives for meeting study requirements. In very rare cases, coercive measures may be justified to prevent immanent harm to others resulting from non-compliance with study requirements.

[1]  J. Hackman,et al.  Three months of rifapentine and isoniazid for latent tuberculosis infection. , 2011, The New England journal of medicine.

[2]  S. Athar.  Principles of Biomedical Ethics , 2011, The Journal of IMA.

[3]  L. Gostin,et al.  Public health measures to control tuberculosis in low-income countries: ethics and human rights considerations. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[4]  D. Gust,et al.  Risk Factors for Non-Adherence and Loss to Follow-Up in a Three-Year Clinical Trial in Botswana , 2011, PloS one.

[5]  David B Resnik,et al.  A national registry for healthy volunteers in phase 1 clinical trials. , 2011, JAMA.

[6]  A. Wertheimer,et al.  The Right to Withdraw from Research , 2010, Kennedy Institute of Ethics journal.

[7]  T. McConnell.  The Inalienable Right to Withdraw from Research , 2010, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.

[8]  A. Wertheimer.  Rethinking the Ethics of Clinical Research: Widening the Lens , 2010 .

[9]  R. Rhodes.  Rethinking Research Ethics , 2010, The American journal of bioethics : AJOB.

[10]  R. Abadie.  The Professional Guinea Pig: Big Pharma and the Risky World of Human Subjects , 2010 .

[11]  E. Emanuel,et al.  The obligation to participate in biomedical research. , 2009, JAMA.

[12]  Eric Chwang.  Against the Inalienable Right to Withdraw from Research , 2008, Bioethics.

[13]  L. Gostin,et al.  Through the Quarantine Looking Glass: Drug-Resistant Tuberculosis and Public Health Governance, Law, and Ethics , 2007, Journal of Law, Medicine & Ethics.

[14]  L. Gostin.  General justifications for public health regulation. , 2007, Public health.

[15]  Frank J Piacenti.  An Update and Review of Antiretroviral Therapy , 2006, Pharmacotherapy.

[16]  D. Resnik,et al.  Strategies to Minimize Risks and Exploitation in Phase One Trials on Healthy Subjects , 2006, The American journal of bioethics : AJOB.

[17]  S. Buchbinder,et al.  Motivations for Participating in an HIV Vaccine Efficacy Trial , 2005, Journal of acquired immune deficiency syndromes.

[18]  S. Edwards.  Research participation and the right to withdraw. , 2005, Bioethics.

[19]  John Harris,et al.  Scientific research is a moral duty , 2005, Journal of Medical Ethics.

[20]  Eric J Topol,et al.  Failing the public health--rofecoxib, Merck, and the FDA. , 2004, The New England journal of medicine.

[21]  Ross Upshur,et al.  Critical reflections on evidence, ethics and effectiveness in the management of tuberculosis: public health and global perspectives , 2004, BMC medical ethics.

[22]  P. Appelbaum,et al.  Therapeutic misconception in clinical research: frequency and risk factors. , 2004, IRB.

[23]  M. Chesney,et al.  The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  A. Wu,et al.  Self‐Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection , 2001, Journal of acquired immune deficiency syndromes.

[25]  J. Kassirer,et al.  Setting the record straight in the breast-cancer trials. , 1994, The New England journal of medicine.

[26]  S. Reiser.  The Patient as Partner: A Theory of Human-Experimentation Ethics , 1988 .

[27]  H. Vanderpool,et al.  False data & the therapeutic misconception: two urgent problems in research ethics. False data and last hopes: enrolling ineligible patients in clinical trials. , 1987, The Hastings Center report.

[28]  E. Lusk,et al.  Attitudes toward clinical trials among patients and the public. , 1982, JAMA.

[29]  James Allan.  Utilitarianism and liberty , 2011 .

[30]  D. Resnik.  The patient's duty to adhere to prescribed treatment: an ethical analysis. , 2005, The Journal of medicine and philosophy.

[31]  C. Herrera.  Universal Compulsory Service in Medical Research , 2003, Theoretical medicine and bioethics.

[32]  Laura Lyman Rodriguez,et al.  Responsible Research: A Systems Approach to Protecting Research Participants , 2003 .

[33]  M. Warnock.  Utilitarianism and on Liberty , 2003 .